Naloxone Hydrochloride
Product Images NDC 0093-2165

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 0093-2165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of naloxone hydrochloride dihydrate showing its molecular components including hydroxyl groups, nitrogen with charge, and water of hydration (2 H2O).*

FDA Label Image

Image 10

Naloxone Hydrochloride Nasal Spray 4 mg label from Teva Pharmaceuticals USA, Inc., NDC 0093-2165. The label includes usage instructions indicating one spray per device with 4 mg strength. Storage details specify 20°C to 25°C with allowable excursions, and warnings against freezing or heat exposure. Additional instructions advise reading the enclosed Quick Start Guide and caution not to test the device before use.*

FDA Label Image

Image 11

An instructional illustration showing hands holding and peeling open a package labeled Naloxone Hydrochloride Nasal Spray 4 mg, manufactured by Teva Pharmaceuticals USA, Inc. The image demonstrates how to remove the nasal spray from its protective packaging.*

FDA Label Image

Image 12

An instructional diagram showing a hand holding a device with labeled parts: 'NOZZLE' at the top and 'PLUNGER' slightly below, indicating components of a drug delivery device.*

FDA Label Image

Image 13

Illustration showing a person administering naloxone by inserting the nasal spray tip into one nostril of a supine individual, with one hand supporting the head and the other squeezing the spray device.*

FDA Label Image

Image 14

An instructional illustration showing a hand holding a nasal spray device, administering a spray into a person's nostril. The spray is depicted as several lines emitting from the nozzle aimed at the nasal cavity.*

FDA Label Image

Image 15

An instructional illustration showing a person lying on their side in a recovery position. Labels indicate that the hand supports the head and the knee stops the body from rolling onto the stomach.*

FDA Label Image

Image 16

Packaging label for Naloxone Hydrochloride Nasal Spray 4 mg/0.1 mL, an intranasal spray containing two units per box. The label displays the proprietary name, dosage strength, and manufacturer as Teva Pharmaceuticals USA, Inc. It includes usage instructions, cautions to check product expiration, and steps for emergency administration of the nasal spray in opioid overdose situations.*

FDA Label Image

Image 17

Naloxone Hydrochloride 1 mg/mL Injection from Teva Pharmaceuticals USA, Inc. The label on a clear glass vial with a gray flip-off cap displays the proprietary name, concentration, and volume of the solution, indicating it is intended for injection. The vial has measurement marks and barcodes visible on the label.*

FDA Label Image

Image 2

Two line graphs showing naloxone plasma concentration (ng/mL) over time (hours postdose) for different naloxone hydrochloride nasal spray and injection doses. Graph (a) covers 0 to 6 hours postdose, while graph (b) focuses on 0 to 1 hour postdose with error bars for variability. Multiple dosing regimens including 2 mg, 4 mg, and 8 mg nasal sprays and 0.4 mg intramuscular injection are compared.*

FDA Label Image

Image 3

Naloxone Hydrochloride Nasal Spray 4 mg label from Teva Pharmaceuticals USA, Inc. The label includes dosage instructions indicating 1 spray per device containing 4 mg naloxone HCl, and storage information specifying to store below 77°F (25°C). It also includes warnings to read the start guide and not to test the device before use.*

FDA Label Image

Image 4

An instructional illustration showing a pair of hands holding and preparing to open a packaging pouch for Naloxone Hydrochloride Nasal Spray, labeler Teva Pharmaceuticals USA, Inc., with product NDC 0093-2165. The image depicts the proper handling of the product packaging before use.*

FDA Label Image

Image 5

Illustration of a hand holding a nasal spray device labeled with arrows pointing to the nozzle and the plunger, demonstrating key parts of the device likely related to Naloxone Hydrochloride nasal spray by Teva Pharmaceuticals.*

FDA Label Image

Image 6

An instructional illustration showing a person receiving a nasal spray administration. One hand is holding the spray device positioned near the nostril, while the other hand supports the person's head, demonstrating the proper technique for nasal administration.*

FDA Label Image

Image 7

An instructional illustration showing the use of a nasal spray device, likely representing administration of Naloxone Hydrochloride nasal spray. The image depicts a hand holding the spray device positioned near a nose, with spray mist directed into the nostril.*

FDA Label Image

Image 8

An instructional diagram illustrating a person in the recovery position lying on their side. Labels indicate that the hand supports the head and the knee stops the body from rolling onto the stomach. This figure is typically used to show proper recovery position technique in first aid.*

FDA Label Image

Image 9

A black and white instructional illustration showing a person kneeling beside another person lying on the ground. The kneeling person is tilting the head of the lying person back, lifting the chin, demonstrating a first aid technique for airway management.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.